共 165 条
[1]
Van de Merwe JP(2008)Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal Eur Urol 53 60-67
[2]
Nordling J(2015)Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment J Urol 193 1545-1553
[3]
Bouchelouche P(2017)The burden of bladder pain in five European countries: a cross-sectional study Urology 99 84-91
[4]
Bouchelouche K(2014)Phenotype-directed management of interstitial cystitis/bladder pain syndrome Urology 84 175-179
[5]
Cervigni M(2014)Interstitial cystitis is bladder pain syndrome with Hunner’s lesion Int J Urol 21 79-82
[6]
Daha LK(2015)Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis? J Urol 193 1994-2000
[7]
Elneil S(2001)The neurobiology and evolution of cannabinoid signalling Philos Trans R Soc Lond B Biol Sci 356 381-408
[8]
Fall M(2011)Inhibition of fatty acid amide hydrolase suppresses referred hyperalgesia induced by bladder inflammation BJU Int 108 1145-1149
[9]
Hohlbrugger G(2007)The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview Am J Ther 14 475-483
[10]
Irwin P(2017)Fatty acid amide hydrolase inhibitor treatment in men with chronic prostatitis/chronic pelvic pain syndrome: an adaptive double-blind, randomized controlled trial Urology 103 191-197